Correlation Between Emergent Biosolutions and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Emergent Biosolutions and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Hepion Pharmaceuticals.
Diversification Opportunities for Emergent Biosolutions and Hepion Pharmaceuticals
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Emergent and Hepion is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Hepion Pharmaceuticals
Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Hepion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Emergent Biosolutions is 1.16 times less risky than Hepion Pharmaceuticals. The stock trades about -0.5 of its potential returns per unit of risk. The Hepion Pharmaceuticals is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 80.00 in Hepion Pharmaceuticals on June 26, 2024 and sell it today you would lose (9.00) from holding Hepion Pharmaceuticals or give up 11.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Emergent Biosolutions vs. Hepion Pharmaceuticals
Performance |
Timeline |
Emergent Biosolutions |
Hepion Pharmaceuticals |
Emergent Biosolutions and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Emergent Biosolutions and Hepion Pharmaceuticals
The main advantage of trading using opposite Emergent Biosolutions and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.Emergent Biosolutions vs. HCW Biologics | Emergent Biosolutions vs. RenovoRx | Emergent Biosolutions vs. Scpharmaceuticals | Emergent Biosolutions vs. Milestone Pharmaceuticals |
Hepion Pharmaceuticals vs. PetIQ Inc | Hepion Pharmaceuticals vs. Emergent Biosolutions | Hepion Pharmaceuticals vs. Neurocrine Biosciences | Hepion Pharmaceuticals vs. Haleon plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |